glp 1 coverage 2025 CVS reports 50% of clients cover GLP-1s for weight loss | Bryce Platt, PharmD posted on the topic kff employer health benefits survey

Microdosing GLP-1 drugs, the class of obesity and diabetes medications that includes Ozempic, Wegovy, Mounjaro, and Zepbound, has emerged as a weight loss trend

So we know that all the data we have, our responsibility is to get the right answer to the patient so they can make their own informed decision about the risk and the benefit

Their prescriber just needs to attest that the BMI criteria was met when therapy began, and that attestation is part of the prior authorization process

Medication access within Measureds program is intentionally framed with limited specificity before intake, with most details resolving only after clinician review

Step 4: Start the Noom app experience

Conclusion There is no universal path to weight loss success or headache freedom